Robeco Institutional Asset Management B.V. Grows Position in DENTSPLY SIRONA Inc (XRAY)
Robeco Institutional Asset Management B.V. lifted its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 440.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 5,062 shares of the medical instruments supplier’s stock after acquiring an additional 4,125 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in DENTSPLY SIRONA were worth $334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Massey Quick Simon & CO. LLC acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $124,000. Huntington National Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $157,000. First Interstate Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $164,000. Stock Yards Bank & Trust Co. purchased a new stake in DENTSPLY SIRONA in the fourth quarter valued at $203,000. Finally, FDx Advisors Inc. purchased a new stake in DENTSPLY SIRONA in the third quarter valued at $220,000. 96.56% of the stock is currently owned by hedge funds and other institutional investors.
Shares of DENTSPLY SIRONA Inc (XRAY) opened at $56.85 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA Inc has a 12 month low of $52.53 and a 12 month high of $68.98. The stock has a market cap of $13,427.26, a PE ratio of -16.38, a PEG ratio of 2.16 and a beta of 1.18.
In other news, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 6,409 shares of the stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the sale, the director now directly owns 12,073 shares in the company, valued at $821,446.92. The disclosure for this sale can be found here. Corporate insiders own 1.99% of the company’s stock.
Several equities research analysts have commented on the stock. HC Wainwright reaffirmed a “hold” rating and issued a $68.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, January 18th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a report on Thursday, October 12th. Robert W. Baird set a $63.00 price target on shares of DENTSPLY SIRONA and gave the company a “buy” rating in a report on Thursday, October 19th. Stifel Nicolaus upped their price target on shares of DENTSPLY SIRONA from $66.00 to $70.00 and gave the company a “buy” rating in a report on Monday, November 6th. Finally, Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a report on Monday, November 6th. Three analysts have rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company. DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $69.15.
ILLEGAL ACTIVITY WARNING: “Robeco Institutional Asset Management B.V. Grows Position in DENTSPLY SIRONA Inc (XRAY)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2018/02/09/robeco-institutional-asset-management-b-v-grows-position-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.